tiprankstipranks
Rein Therapeutics (RNTX)
NASDAQ:RNTX
US Market
RNTX
Rein Therapeutics
RESEARCH TOOLSreports

Rein Therapeutics (RNTX) Income Statement

Compare
1,195 Followers

Rein Therapeutics Income Statement

Last quarter (Q3 2024), Rein Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Rein Therapeutics's net income was $-5.85M. See Rein Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -119.00K$ -169.00K$ -121.00K$ -163.00K$ -155.00K
Operating Expenses
$ 16.28M$ 27.65M$ 26.61M$ 20.50M$ 29.96M
Depreciation and Amortization
$ 119.00K$ 169.00K$ 121.00K$ 163.00K$ 155.00K
EBITDA
$ -15.61M$ -27.48M$ -26.48M$ -20.33M$ -29.80M
Operating Income
$ -16.28M$ -27.65M$ -26.61M$ -20.50M$ -29.96M
Other Income/Expenses
$ 544.00K$ 318.00K$ 441.00K$ -661.00K$ 587.00K
Pretax Income
$ -15.73M$ -27.33M$ -26.20M$ -21.16M$ -29.37M
Net Income
$ -15.73M$ -27.01M$ -25.76M$ -21.82M$ -28.78M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.42$ -5.95$ -5.80$ -12.52$ -23.46
Diluted EPS
$ -3.42$ -5.95$ -5.80$ -12.52$ -23.46
Weighted Average Shares Outstanding
4.60M 4.54M 4.44M 1.74M 1.23M
Weighted Average Shares Outstanding (Diluted)
4.60M 4.54M 4.44M 1.74M 1.23M
Currency in USD

Rein Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis